Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q4 2020 Earnings Presentation
13 slides from Phibro Animal Health's earnings presentation, Aug 27, 2020
Slide 1: Phibro Animal Health Corporation Fourth Quarter Webcast and Conference Call
Phibro Animal Health Corporation Fourth Quarter – June 30, 2020 U.S. toll-free +1-833-968-1955 Webcast and Conference Call International toll +1-647-689-6656 August 27, 2020 Conference ID: 2577655
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: GAAP and Non-GAAP Financial Information
GAAP and Non-GAAP Financial Information Reported results are presented in accordance with GAAP Adjusted results are GAAP results adjusted to exclude - Acquisition-related items, including intangible amortization, cost of goods sold, accrued compensation costs, transaction costs and adjustments to co
Slide 4: Opening Remarks and Financial Review
Opening Remarks and Financial Review Jack Bendheim Chairman, President, Chief Executive Officer Richard Johnson Chief Financial Officer 4 August 27, 2020 Webcast and Conference Call
Slide 5: Highlights
Highlights Q4 – June 2020 Consolidated Short-term decline in product demand due to COVID-19. Sales declines in the Animal Health, Mineral Nutrition and Performance Products For the three months ended 2020 2019 Change businesses, primarily due to lower volume. In June 30 (in millions, except per shar
Slide 6: Selected Line Items
Selected Line Items Q4 – June 2020 Consolidated Adjusted gross profit - Animal Health volume decline in MFAs and other For the three months ended June 30 2020 2019 Change was partially offset by increased sales in (in millions, except per share amounts and percentages) nutritional specialty products
Slide 7: Animal Health
Animal Health Q4 – June 2020 Animal Health MFAs and other For the three months ended - Lower demand in China, South America and other 2020 2019 Change June 30 international regions (in millions, except percentages) - Lower demand in China due to ASF and phased MFAs and other $ 72.6 $ 86.3 $ (13.7) (
Slide 8: Other Segments
Other Segments Q4 – June 2020 For the three months ended 2020 2019 Change June 30 Mineral Nutrition (in millions, except percentages) Mineral Nutrition - Sales decreased due to lower average selling Net sales $ 49.9 $ 56.0 $ (6.1) (11)% prices and lower overall volumes - Adjusted EBITDA decrease dri
Slide 9: Selected Line Items
Selected Line Items Year – June 2020 Consolidated MFAs and other - Driven primarily by lower demand in China due to ASF and phased regulatory change beginning January 1, For the year ended June 30 2020 2019 Change 2020 (in millions, except per share amounts and percentages) Net sales $ 800.4 $ 828.0
Slide 10: Capitalization
Capitalization June 30, 2020 3.8x leverage ratio at June 30, 2020 - $388 million total debt - $102 million Adjusted EBITDA $91 million cash and short-term investments on hand at June 30, 2020 $6 million use of cash before financing for the June 2020 quarter, including $10 million of capital expendit
Slide 11: Guidance for our September 2020 Quarter
Guidance for our September 2020 Quarter We are forecasting only short-term expectations, given the ongoing difficult conditions in the industry. The animal production industry continues to face demand disruption and production impacts. We believe the current situation will begin to normalize as we p
Slide 12: Q&A Session
Q&A Session 12 August 27, 2020 Webcast and Conference Call
Slide 13: © 2020 Phibro Animal Health Corporation
© 2020 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that